f16sip
mAbexperimentalADC
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT01240720)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Payload
- 131-iodine
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109584 ↗
Also known as
- 131i-f16sip
- f16sip
- f16sip 131i
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01240720 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2008 | Eudax S.r.l., Istituto Nazionale per lo Studio e la Cura dei Tumori, Philogen S.p.A. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eudax S.r.l. | For profit | 1 | 0 | 1 | 2008 |
| Istituto Nazionale per lo Studio e la Cura dei Tumori | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Philogen S.p.A. | For profit | 1 | 1 | 1 | 2008 |
3 organizations
Page 1 / 1